数据链接：
官方服务：
资源简介：
Data for Plos One Beta-blocker treatment of headache
应用场景：
创建时间：
2019-02-05
相关数据集
Table_1_Acute Medication Use in Patients With Migraine Treated With Monoclonal Antibodies Acting on the CGRP Pathway: Results From a Multicenter Study and Proposal of a New Index.DOCX
IntroductionAssessing the impact of migraine preventive treatments on acute medication consumption is important in clinical evaluation. The number of acute medication intakes per each monthly migraine
NIAID Data Ecosystem60
Use of triptans and associated factors: Prevelence Ratios (PR) and 95% Confience Intervals (95% CI).
Use of triptans and associated factors: Prevelence Ratios (PR) and 95% Confience Intervals (95% CI).
NIAID Data Ecosystem20
Dataset from An Open-label, LonG-term, Safety Study of LAsmiDItan (100 mg and 200 mg) in the Acute Treatment Of MigRaine (GLADIATOR)
This is a prospective, randomized, open-label study in subjects with migraine who have completed the Phase 3 studies, COL MIG 301/LAHJ (NCT02439320) or COL MIG-302/LAHK (NCT02605174) or for a subset
NIAID Data Ecosystem10
sj-xlsx-2-cep-10.1177_0333102421991809 - Supplemental material for Twenty-five years of triptans – a nationwide population study
Supplemental material, sj-xlsx-2-cep-10.1177_0333102421991809 for Twenty-five years of triptans – a nationwide population study by Olafur B Davidsson, Isa A Olofsson, Lisette JA Kogelman, Michael Asge
DataCite Commons2024-08-28 更新20
Clinical outcomes during a 3-year follow-up in patients with mildly reduced left ventricular systolic function according beta-blocker therapy at discharge.
Clinical outcomes during a 3-year follow-up in patients with mildly reduced left ventricular systolic function according beta-blocker therapy at discharge.
Figshare2025-06-23 更新10
